Safety and efficacy of endoscopic papillectomy for duodenal papillary adenomas: A single-center retrospective study

Table 1 Baseline characteristics of patients, n (%)

	PD (n = 37)	EP (n = 37)	t/χ2	P value
Age (year)	61.35 ± 8.11	62.83 ± 11.32	-0.649	0.518
Gender
Male	17 (45.95)	25 (67.75)	3.52	0.06
Female	20 (54.05)	12 (32.43)
Tumor size (cm)	1.94 ± 0.77	1.94 ± 0.85	0.123	0.481
Previous abdominal surgery
No	25 (67.57)	28 (75.68)	0.598	0.439
Yes	12 (32.43)	9 (24.32)
Hypertension
No	21 (56.76)	24 (64.86)	0.51	0.475
Yes	16 (43.24)	13 (35.14)
Diabetes
No	34 (91.89)	32 (86.49)	0.561	0.454
Yes	3 (8.11)	5 (13.51)
Coronary heart disease
No	36 (97.30)	35 (94.59)	0.347	0.556
Yes	1 (2.70)	2 (5.41)
Anticoagulant
No	36 (97.30)	36 (97.30)	0.01	0.99
Yes	1 (2.70)	1 (2.70)
CBC
Hemameba	6.14 ± 2.34	5.90 ± 1.48	0.534	0.595
Hemoglobin	124.70 ± 26.34	134.14 ± 19.14	-1.762	0.082
Blood platelet	212.76 ± 65.93	187.14 ± 60.09	1.747	0.085
Blood coagulation
PT	11.93 ± 1.10	12.92 ± 2.44	-2.239	0.58
APTT	26.96 ± 3.64	27.68 ± 3.95	-0.811	0.42
Biochemical function
Total bilirubin	26.59 ± 33.75	12.08 ± 5.75	2.578	0.012
Direct bilirubin	16.88 ± 26.77	3.71 ± 1.58	2.987	0.004
Albumin	39.70 ± 4.289	40.00 ± 2.45	-0.37	0.713
Urea nitrogen	4.61 ± 1.66	5.20 ± 1.42	-1.659	0.102
Creatinine	59.00 ± 12.43	68.03 ± 18.48	-2.465	0.058
Tumor marker
CA19-9	21.32 ± 27.53	13.92 ± 10.55	1.526	0.131

P < 0.05 indicated statistical significance. CBC: Complete blood count; PD: Pancreaticoduodenectomy; EP: Endoscopic papillectomy; PT: Prothrombin time; APTT: Activated partial thromboplastin time; CA19-9: Carbohydrate antigen 19-9.